Skinvisible Inc Quick Ratio (SKVI) starting from the second quarter 2026 to second quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Skinvisible Inc   (SKVI)

Skinvisible Inc 's Quick Ratio

SKVI's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the second quarter 2026, Quick Ratio fell to 0 a new company low.

Within Major Pharmaceutical Preparations industry 456 other companies have achieved higher Quick Ratio than Skinvisible Inc in second quarter 2026. While Quick Ratio total ranking has improved so far during the Q2 2026 to 4629, from total ranking in the first quarter 2026 at 5560.

Explain Quick Ratio?
How much Cash & cash equivalents SKVI´s has?
What are SKVI´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

SKVI Quick Ratio (Jun 30 2026)
Q2		 (Mar 31 2026)
Q1		 (Dec 31 2025)
Q4		 (Sep 30 2025)
Q3		 (Jun 30 2025)
Q2
Y / Y Current Liabilities Change 24.29 % 26.19 % 26.53 % -5.17 % 3.47 %
Y / Y Cash & cash equivalent Change 3199.17 % -86.58 % -74.65 % 5.39 % -98.28 %
Quick Ratio MRQ 0 0 0 0 0
SKVI's Total Ranking # 4629 # 5560 # 5450 # 5575 # 5481
Seq. Current Liabilities Change 5.28 % 5.56 % 5.73 % 5.78 % 6.89 %
Seq. Cash & cash equivalent Change 120.19 % -31.37 % 306.2 % 437.5 % -99.1 %



Quick Ratio second quarter 2026 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 457
Healthcare Sector # 932
Overall Market # 4525


Quick Ratio Statistics
High Average Low
0.68 0.05 0
(Dec 31 2012)   (Jun 30 2025)




Financial Statements
Skinvisible Inc 's Current Liabilities $ 5 Millions Visit SKVI's Balance sheet
Skinvisible Inc 's Cash & cash equivalent $ 0 Millions Visit SKVI's Balance sheet
Source of SKVI's Sales Visit SKVI's Sales by Geography


Cumulative Skinvisible Inc 's Quick Ratio

SKVI's Quick Ratio for the trailling 12 Months

SKVI Quick Ratio

 (Jun 30 2026)
12 Months		 (Mar 31 2026)
12 Months		 (Dec 31 2025)
12 Months		 (Sep 30 2025)
12 Months		 (Jun 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth 16.89 % 11.67 % 4.11 % -0.82 % 10.13 %
Y / Y Cash & cash equivalent TTM Growth -63.12 % -83.46 % -35.54 % 47.69 % 46.44 %
Quick Ratio TTM 0 0 0 0 0
Total Ranking TTM # 4179 # 4805 # 3677 # 3735 # 3781
Seq. Current Liabilities TTM Growth 5.58 % 5.96 % 6.05 % -1.47 % 0.86 %
Seq. Cash & cash equivalent TTM Growth 74.07 % -69.11 % -31.5 % 0.13 % -21.93 %

Quick ratio ranking by company, industry and sector >> Back to SKVI Financial Strength Comparisons >> Go to Compare SKVI Quick Ratio to its Competitors

On the trailing twelve months basis In Spite of the rise in Current Liabilities in the Q2 2026 to $5.17 millions, cumulative Quick Ratio